Improved post‐transplant outcomes since 2000 for Ph‐positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party

Abstract Allogeneic hematopoietic cell transplantation (allo‐HCT) remains a curative treatment for patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ ALL) in their first complete remission (CR1). Recent results using the combination of blinatumomab and second‐ or third‐...

詳細記述

書誌詳細

出版年:	HemaSphere
主要な著者:	Ali Bazarbachi, Myriam Labopin, Iman Abou Dalle, Ibrahim Yakoub‐Agha, Gérard Socié, Thomas Schroeder, Didier Blaise, Xavier Poiré, Marie Balsat, Urpu Salmenniemi, Nicolaus Kröger, Alexander Kulagin, Eva Maria Wagner‐Drouet, Depei Wu, Eolia Brissot, Arnon Nagler, Sebastian Giebel, Fabio Ciceri, Mohamad Mohty
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2025-04-01
オンライン･アクセス:	https://doi.org/10.1002/hem3.70117